About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 6,421–6,430 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 6,322 |
Contemporary Mathematics CONTEMP MATH-SINGAP |
2705-1064 2705-1056 |
2.500 | 2.000 | Q1 | 21/483 | Universal Wiser Publisher |
| 6,322 |
Cost Effectiveness and Resource Allocation COST EFFECT RESOUR A |
1478-7547 1478-7547 |
2.500 | 2.600 | Q2 | 48/124 | BMC |
| 6,322 |
Critical Finance Review CRIT FINANC REV |
2164-5744 2164-5760 |
2.500 | 2.200 | Q2 | 78/241 | NOW PUBLISHERS INC |
| 6,322 |
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS CRIT REV THER DRUG |
0743-4863 2162-660X |
2.500 | 3.000 | Q3 | 181/352 | BEGELL HOUSE INC |
| 6,322 |
Critical Studies on Terrorism CRIT STUD TERROR |
1753-9153 1753-9161 |
2.500 | 2.700 | Q1 | 63/322 | TAYLOR & FRANCIS LTD |
| 6,322 |
Crop Protection CROP PROT |
0261-2194 1873-6904 |
2.500 | 3.000 | Q1 | 31/129 | ELSEVIER SCI LTD |
| 6,322 |
Current Developmental Disorders Reports CURR DEV DISORD REP |
N/A 2196-2987 |
2.500 | 2.800 | Q1 | 29/173 | SPRINGERNATURE |
| 6,322 |
CURRENT DRUG TARGETS CURR DRUG TARGETS |
1389-4501 1873-5592 |
2.500 | 3.300 | Q3 | 181/352 | BENTHAM SCIENCE PUBL LTD |
| 6,322 |
CURRENT MOLECULAR MEDICINE CURR MOL MED |
1566-5240 1875-5666 |
2.500 | 2.400 | Q3 | 102/195 | BENTHAM SCIENCE PUBL LTD |
| 6,322 |
CURRENT OPINION IN GASTROENTEROLOGY CURR OPIN GASTROEN |
0267-1379 1531-7056 |
2.500 | 2.500 | Q2 | 68/147 | LIPPINCOTT WILLIAMS & WILKINS |